Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Insite Vision Inc. -- Ignore unavailable to you. Want to Upgrade?

To: David Bogdanoff who wrote (938)	5/29/1999 1:54:00 PM
From: bob zagorin	Read Replies (1) \| Respond to of 1060

when is annual meeting?

To: David Bogdanoff who wrote (938)	5/31/1999 12:25:00 AM
From: Awashonks	Read Replies (1) \| Respond to of 1060

I am sorry, I must have not been clear. The present PhaseII trial tested patients with steroid-induced glaucoma. The next Phase II trial will test an expanded indication. It will test patients with all other types of glaucoma. My understanding is that they expect the trial to go well given the indications in the original Phase II trial. For further info, call Sandi Heine at ISV, she is very helpful. All the best, Awashonks